236 related articles for article (PubMed ID: 4075908)
1. [Combined therapy of carbidopa and levodopa in Parkinson's disease].
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):201-4. PubMed ID: 4075908
[No Abstract] [Full Text] [Related]
2. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
Lombardo L; De la Garza R
Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
[TBL] [Abstract][Full Text] [Related]
3. The effects of combining carbidopa with levodopa for Parkinson's disease.
Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB
Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406
[No Abstract] [Full Text] [Related]
4. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
Pahwa R; Koller WC
Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
[No Abstract] [Full Text] [Related]
5. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
Londoõ R
Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
[TBL] [Abstract][Full Text] [Related]
6. Amantadine and a fixed combination of levodopa and carbidopa in the treatment of Parkinson's disease.
Savery F
Dis Nerv Syst; 1977 Aug; 38(8):605-8. PubMed ID: 328244
[TBL] [Abstract][Full Text] [Related]
7. Use of carbidopa as an adjuvant to levodopa/carbidopa therapy in patients with Parkinson's disease.
Lieberman AN; Gopinathan G; Neophytides A; Pasternack P
N Y State J Med; 1986 Dec; 86(12):655-6. PubMed ID: 3468386
[No Abstract] [Full Text] [Related]
8. [Effects and side effects to levodopa in parkinsonism- results of a collaborative study. (5) Combined therapy with a peripheral decarboxylase inhibitor].
Omoto T
Rinsho Shinkeigaku; 1976 Dec; 16(12):879-80. PubMed ID: 1035531
[No Abstract] [Full Text] [Related]
9. Response to Sinemet 25/100 in Parkinson's disease.
Ulm G; Gerdes U; Lehmann K
Adv Neurol; 1984; 40():541-7. PubMed ID: 6695634
[No Abstract] [Full Text] [Related]
10. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
[TBL] [Abstract][Full Text] [Related]
11. Sinemet in Parkinson's disease: efficacy with and without food.
Bozek CB; Suchowersky O; Purves S; Calne S; Calne DB
Clin Neuropharmacol; 1986; 9(2):196-9. PubMed ID: 3708604
[No Abstract] [Full Text] [Related]
12. Parkinson's disease improvement after the addition of levodopa-carbidopa to anticholinergic treatment. An open controlled study.
Agnoli A; Ruggieri S; Denaro A; Lelli A
Acta Neurol (Napoli); 1978 Oct; 33(5):436-42. PubMed ID: 756675
[No Abstract] [Full Text] [Related]
13. Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.
Fermaglich J
Med Ann Dist Columbia; 1974 Dec; 43(12):587-91. PubMed ID: 4532167
[No Abstract] [Full Text] [Related]
14. [Combined treatment of Parkinsonism with L-dopa and peripheral dopa decarboxylase inhibitors--clinical course of 13 cases and levels of serum/dopa and dopamine].
Mizuno Y; Yoshida M; Obayashi T; Ueki A
Rinsho Shinkeigaku; 1976 Jul; 16(7):511-9. PubMed ID: 986921
[No Abstract] [Full Text] [Related]
15. [Usefulness of increasing the proportion of carbidopa to levodopa in the long-term treatment of Parkinson's disease].
Bermejo Pareja F; Martínez-Martín P
Med Clin (Barc); 1984 Feb; 82(7):305-10. PubMed ID: 6717135
[No Abstract] [Full Text] [Related]
16. Sinemet CR for Parkinson's disease.
Med Lett Drugs Ther; 1991 Oct; 33(854):92-3. PubMed ID: 1895993
[No Abstract] [Full Text] [Related]
17. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of bromocriptine and levodopa in Parkinson's disease.
Duvoisin RC; Mendoza MM; Yahr MD
Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
[No Abstract] [Full Text] [Related]
19. The long-term effects of combining carbidopa with levodopa for Parkinson's disease.
Lee MC; Lippert DM; Loewenson RB; Tolosa ES; Resch JA; Martin WE
Trans Am Neurol Assoc; 1976; 101():262-4. PubMed ID: 829295
[No Abstract] [Full Text] [Related]
20. New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation. London, England, April 28 and 29, 1989. Proceedings.
Neurology; 1989 Nov; 39(11 Suppl 2):1-106. PubMed ID: 2586761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
